|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Complement Factor P (Properdin) Quantitative Assay | Amyloid Beta (1-40) ELISA Assay | Anti-Ustekinumab (Stelara®) ELISA | hGH (High Sensitivity) ELISA Assay | Vitamin D3, 1-25-OH RIA CT Assay |
| Citations | | | | | |
| Catalog Number | COMPL FPQ RUO | 27713 | TM09036 | E022 | KIR1929 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | The Wieslab® Complement Factor P Quantitative Assay (COMPL FPQ) is an enzyme immunoassay (ELISA) for the quantitation of the amount of human Factor P in test samples. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of human Aß(1-40) in EDTA-plasma, cerebrospinal fluids, serum, cell culture media or the extract from brain tissue. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Enzyme immunoassay (ELISA) for the measurement of levels of human growth hormone in serum and plasma. Human growth hormone measurements are used in the diagnosis and treatment of disorders involving the anterior lobe of the pituitary gland. For research use only, not for use in diagnostic Enzyme immunoassay (ELISA) for the measurement of levels of human growth hormone in serum and plasma. Human growth hormone measurements are used in the diagnosis and treatment of disorders involving the anterior lobe of the pituitary gland. For research use only, not for use in diagnostic procedures.
The endocrine system of Human Growth Hormone (hGH), also named Somatropin, is characterized by extreme complexity.... Read More | Radioimmunoassay (RIA) for the determination of human 1,25(OH)2-Vitamin D (1,25(OH)2-Vit.D) in serum and plasma. For research use only, not for use in diagnostic procedures. |
| Detection Target | Complement Factor P (Properdin) | Anti-Rituximab (Rituxan®) | sAPP Total | Adrenaline | Lysozyme |
| Sample Type | Serum, Blood Plasma | Serum and plasma. | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Tissue Extracts, Dialysates, Urine Blood Plasma | Serum, Stool, Blood Plasma |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Radio Immuno Assay (RIA) |
| Detection Range | 0 / 12.5 - 200 ng/mL | 7.81 to 500 pg/mL | Anti-Ustekinumab (Stelara®) | 50 to 1,000 pg/mL | 4.7 to 411 pg/mL |
| Sensitivity | 93.55% (95% confidence interval: 89.41% - 96.43%) | 40 ng/mL | 0.06 ng/mL | 0.25 ng/mL x C (must be multipled by a correction factor dependent on sample volume). | Inquire |
| Assay Time | 60 min. (RT) + 30 min. (RT) + 30 min. (RT) = 2 hours incubation time. | Overnight + 1 hr 30 mins (incubation) | 2 hour, 30 min. total incubation time. | 3 hr 15 mins (incubation) | Overnight + 15 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |